Company page

Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a public company listed under the ticker GENB, operating in the American market. The company has a market capitalization of approximately $1.74 billion. Generate Biomedicines focuses on developing innovative biomedicine solutions.

GENB:NASDAQUpdated September 12, 2026
Generate Biomedicines, Inc. logo
Ticker
GENB:NASDAQ
Asset type
Stock
Market cap
$2.02B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD